2 unchanged sentences
Filed/Furnished
−Removed: Lease Agreement dated as of September 8, 2021, by and between ARE-MA Region No.
−Removed: 24, LLC, and the Registrant.
−Removed: Amendment to Sublease dated as of September 8, 2021, by and between Homology Medicines, Inc., and the Registrant.
+Added: License and Collaboration Agreement, dated as of January 9, 2022, by and between Acadia Pharmaceuticals Inc.
+Added: and the Registrant.
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
12 unchanged sentences
This certification is deemed not filed for purposes of section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of the Exchange Act.
+Added: † Registrant has omitted portions of the exhibit as permitted under Item 601(b)(10) of Regulation S-K.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
STOKE THERAPEUTICS, INC.
−Removed: November 8, 2021
/s/ Edward M.
1 unchanged sentence
(Principal Executive Officer)
−Removed: November 8, 2021
/s/ Stephen J.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.